How much does a tube of Bortezomib cost?

Bortezomib (Bortezomib) is an innovative drug that has made significant breakthroughs in the field of cancer treatment. It belongs to the proteasome inhibitor drug class, which acts on the proteasome structure in cells and has excellent targeted therapeutic properties.

Bortezomib is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of around 3,000 to 4,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement policies. The cheaper ones abroad are mainly Indian generic drugs, which cost around 1,000 yuan and have basically the same ingredients as the domestic bortezomib drug.

The drug is most widely used in the treatment of multiple myeloma (Multiple Myeloma ). Multiple myeloma is a hematological malignancy in which patients have abnormal plasma cells in their bone marrow, leading to bone destruction and a compromised immune system. By inhibiting the activity of the proteasome, bortezomib reduces the proliferation of plasma cells and the growth of cancer cells, thereby improving the patient's quality of life and survival rate.

Different from traditional chemotherapy drugs, bortezomib is more specific in its effect and mainly targets cancer cells, reducing damage to healthy cells. This property reduces the incidence of side effects such as nausea, vomiting and hair loss, making the treatment more acceptable.

Bortezomib is also widely used to treat certain hematological tumors such as non-Hodgkin lymphoma (Non-Hodgkin Lymphoma ). Its efficacy and safety make it a powerful weapon against these diseases.

In general, bortezomib represents a major advancement in modern cancer treatment. With its targeted and side-effect reduction properties, bortezomib provides new treatment hope for cancer patients and has also made significant achievements in the medical field.